[c09aa8]: / clusters / 9knumclustersv2 / clust_2981.txt

Download this file

65 lines (64 with data), 4.7 kB

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
Ongoing sensory or motor neuropathy Grade ?.
No grade >= peripheral motor or sensory neuropathy
Neuropathy (sensory and motor) =< CTCAE v . grade
Neuropathy (sensory and motor) less than or equal to CTCAE grade
Patients must have < grade neuropathy (sensory/motor) within days prior to registration
Subject has preexisting sensory or motor neuropathy Grade ? at baseline
Participants with grade >= peripheral motor or sensory neuropathy
Neuropathy (sensory and motor) NCI CTCAE grade =<
Neuropathy (sensory and motor) less than or equal to CTCAE v., grade
Patients who have pre-existing motor or sensory neuropathy of a severity ? grade by CTCAE v. criteria
Grade ? sensory or motor neuropathy.
Has not recovered from adverse reactions to prior myeloma treatment or procedures (chemotherapy, immunotherapy, radiation therapy) to NCI CTCAE less than or equal to (<=) Grade or baseline, except for sensory or motor neuropathy which should have recovered to <=Grade or baseline.
Sensory or motor neuropathy ? grade
Preexisting motor neuropathy Grade ?
Neuropathy (sensory and motor) less than or equal to CTCAE v. grade
Sensory or motor neuropathy >= grade
Ongoing sensory or motor neuropathy Grade or higher.
Sensory or motor neuropathy >= Grade .
Neuropathy (sensory and motor) =< to CTCAE grade
Patients with symptomatic peripheral motor or sensory neuropathy >= grade at baseline will receive radiation therapy alone
Neuropathy (sensory and motor) less than or equal to grade per Common Toxicity Criteria (CTC) version
Grade sensory neuropathy or motor neuropathy with pain
Sensory/motor neuropathy >= grade
Sensory/motor neuropathy >= grade
Patients with any of the following adverse events at the time of enrollment are not eligible:\r\n* Grade ? motor, sensory or peripheral neuropathy\r\n* Grade ? hyponatremia (serum sodium [Na] ? mmol/L)
Participant must have either no neuropathy (sensory and motor) or neuropathy less than or equal to grade
Patients with persistent grade or higher peripheral sensory or motor neuropathy of any cause
Sensory or motor peripheral neuropathy >= grade
Sensory or motor neuropathy >= grade
Subject has preexisting sensory or motor neuropathy Grade ? at baseline
Pre-existing >= grade sensory or motor peripheral neurotoxicity
Patients must not have a pre-existing > grade motor or sensory neuropathy
PHASE II: Patients must not have a pre-existing > grade motor or sensory neuropathy
Neuropathy (sensory and motor) =< grade
Neuropathy (sensory and motor) less than or equal to CTEP CTCAE version ., grade
Pre-existing peripheral motor or sensory neuropathy >= grade
Neuropathy (sensory and motor) less than or equal to Grade .
Preexisting sensory neuropathy Grade ? or motor neuropathy Grade ?
Motor neuropathy considered of autoimmune origin
Sensory or motor peripheral neuropathy
Neuropathy (sensory and motor) less than or equal to grade
Neuropathy (sensory and motor) less than or equal to grade
Preexisting sensory and/or motor neuropathy Grade ?
History of severe motor or sensory neuropathy, or any other autoimmune disorder which is deemed to be significant
CTC Grade or greater neuropathy (motor or sensory) from comorbidity other than prior taxane exposure, such as diabetes.
Neuropathy (sensory and motor) less than or equal to CTCAE grade
Neuropathy(Both motor and sensory) ? Grade (CTCAE Version .)
Neuropathy (sensory and motor) less than or equal to grade
Neuropathy (sensory and motor) less than or equal to CTCAE v . grade
Patients with pre-existing Grade (or greater) peripheral motor or sensory neurotoxicity per the CTCAE . as determined by the treating physician or a neurologist.
Evidence of baseline sensory or motor neuropathy
Neuropathy (sensory and motor) =< CTCAE v. grade
Significant peripheral sensory or motor neuropathy at the start of the study.
Has sensory or motor neuropathy limiting daily activities.
Neurologic function: neuropathy (sensory and motor) ? CTCAE Grade
Current/ongoing Neuropathy (sensory or motor) Grade > or any history of Grade ? neuropathy with prior Vincristine or chemotherapy exposure (documentation by history is adequate to exclude)
Greater than grade motor neuropathy or greater than grade sensory neuropathy at screening
Neuropathy (sensory and motor) less than or equal to CTCAE grade
Grade or greater motor or sensory neuropathy
Patients with >= grade sensory or motor neuropathy are not eligible
Neuropathy (sensory or motor) less than or equal to grade
Able to perform motor/sensory tests
Sensory/motor neuropathy ? Grade
Current or prior history of grade ? peripheral sensory and/or motor neuropathy.